help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laufer, N.
Right arrow Articles by Behrman, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laufer, N.
Right arrow Articles by Behrman, H. R.

Journal of Clinical Endocrinology & Metabolism, Vol 58, 430-434, Copyright © 1984 by Endocrine Society


ARTICLES

Gonadotropin and prolactin levels in follicular fluid of human ova successfully fertilized in vitro

N Laufer, W Botero-Ruiz, AH DeCherney, F Haseltine, ML Polan and HR Behrman

Follicular fluid (FF) and oocytes were obtained from 94 follicles of 36 women for fertilization in vitro. Ovulation was induced with human menopausal gonadotropin, and follicular aspiration was performed 36 h after an ovulatory injection of hCG. The concentrations of immunoreactive hCG, FSH, and PRL were correlated with the degree of maturation of the oocyte-corona-cumulus complex mass (OCCC), fertilization, rate of cleavage, and the incidence of pregnancy after embryo transfer. Immature OCCC were derived from follicles that contained significantly lower levels of FSH than those from which intermediate and mature OCCC were derived (5.2 +/- 0.6 vs. 11.1 +/- 1.2 mlU/ml; P less than 0.05). FF from oocytes that were successfully fertilized contained higher levels of both hCG and FSH than FF surrounding oocytes that did not fertilize (136.7 +/- 8.7 vs. 108.5 +/- 10.3 mlU/ml hCG; 10.55 +/- 0.6 vs. 5.3 +/- 0.8 mIU FSH, respectively). There was no correlation between early embryonic growth rate and FF concentrations of FSH, hCG, and PRL. Ova reaching the two-cell stage 40 h after fertilization in vitro were associated with the same FF concentrations of FSH, hCG, and PRL as those that cleaved to the four- cell stage. The PRL concentration in FF was significantly higher in mature fertilized ova and in fertilized ova that were associated with a successful pregnancy. It is suggested that the intrafollicular concentration of FSH is associated with the degree of mucification of the OCCC, but FF levels of both FSH and hCG are associated with successful fertilization. High levels of PRL in FF were associated with successful pregnancy and may imply a role of this hormone in oocyte maturation.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
N. P. Vlahos, E. M. Bugg, M. J. Shamblott, J. Y. Phelps, J. D. Gearhart, and H. A. Zacur
Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells
Mol. Hum. Reprod., November 1, 2001; 7(11): 1033 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
Endocr. Rev., June 1, 1998; 19(3): 225 - 268.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Jinno, Y. Katsumata, T. Hoshiai, Y. Nakamura, K. Matsumoto, and Y. Yoshimura
A Therapeutic Role of Prolactin Supplementation in Ovarian Stimulation for in Vitro Fertilization: The Bromocriptine-Rebound Method
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3603 - 3611.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C J Ormandy, A Camus, J Barra, D Damotte, B Lucas, H Buteau, M Edery, N Brousse, C Babinet, N Binart, et al.
Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.
Genes & Dev., January 15, 1997; 11(2): 167 - 178.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
G. C. Wolf, C. R. Sanborn, J. Thompson, L. M. Wagley, H. Mizuma, and C. W. Hilton
Identification of Cyclo(His-Pro)-Like Immunoreactivity in Human Follicular Fluid: Correlation With Steroid and Peptide Hormones
Reproductive Sciences, July 1, 1994; 1(3): 220 - 224.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society